{"id":"doi:10.1001/jama.2021.1831","kind":"article","title":"Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity","authors":["Thomas A. Wadden","Timothy Silleck Bailey","Liana K. Billings","Melanie Jane Davies","Juan P. Frías","Anna Koroleva","Ildiko Lingvay","Patrick Mahlen O'Neil","Domenica Rubino","Dorthe Charlotte Skovgaard","Signe Olrik Rytter Wallenstein","William Timothy Garvey","STEP 3 Investigators"],"author_count":13,"year":2021,"published":"2021-02-24","venue":"JAMA","cited_by":1113,"doi":"10.1001/jama.2021.1831","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1001/jama.2021.1831","archive_url":"https://space-kitty.com/papers/doi:10.1001/jama.2021.1831","updated":null,"pmid":"33625476","pmcid":null,"openalex_id":"W3129305070","pdf_url":"https://jamanetwork.com/journals/jama/articlepdf/2777025/jama_wadden_2021_oi_210014_1618250237.04792.pdf","abstract":null,"abstract_license":null,"license":null,"is_open_access":true,"retracted":false,"peer_reviewed":null,"categories":["Pharmacology and Obesity Treatment"],"details":null,"provenance":"openalex","attribution":"Metadata and citation counts: OpenAlex (CC0).","topics":[{"slug":"glp1-metabolic","name":"GLP-1 & Incretin Therapies","domain_slug":"medicine"}],"cited_in_dossiers":[{"slug":"glp1-metabolic","title":"GLP-1 & Incretin Therapies: State of the Field (October 2026)","url":"https://space-kitty.com/dossiers/glp1-metabolic"}]}